TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference on Wednesday, May 20, 2009. The presentation, which is scheduled for 11:00 a.m. Eastern Time, will provide a brief overview of the Company and include a question-and-answer session with a Leerink Swann analyst. The session may be accessed through the Company’s web site, www.regeneron.com, on the Investor Relations page under the Presentations heading. An archived version of the presentation will be available after the live webcast through June 19, 2009. Additional information about Regeneron and recent news releases are available on the Regeneron web site.
